Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Effect of a Multispecies Probiotics on Autism Symptoms in Children
Sponsor: Medical University of Warsaw
Summary
In this trial, the investigators aim to evaluate the impact of a multispecies probiotic consisting of Bacillus subtilis W201, Bifidobacterium infantis W17, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus rhamnosus W140, Lactococcus lactis W19, Propionibacterium freudenreichii W200, on the severity of autism symptoms, quality of life, gastrointestinal symptoms, sleep disturbances, parental stress levels and urinary p-cresol concentrations in children with Autism Spectrum Disorder aged 7 to 15 years.
Key Details
Gender
All
Age Range
7 Years - 15 Years
Study Type
INTERVENTIONAL
Enrollment
110
Start Date
2024-08-07
Completion Date
2026-07-30
Last Updated
2026-01-08
Healthy Volunteers
No
Conditions
Interventions
Multispecies probiotics
Multispecies probiotics consisting of Bacillus subtilis W201, Bifidobacterium infantis W17, Bifidobacterium lactis W51, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus rhamnosus W140, Lactococcus lactis W19, Propionibacterium freudenreichii W200 at a dose of 5x10\^9 Colony Forming Units (CFU), once daily, orally.
Placebo
Placebo identical in taste, smell and color to the multispecies probiotics.
Locations (3)
Department of Paediatrics, The Medical University of Warsaw
Warsaw, Warsaw, Poland
Department of Paediatrics, The Medical University of Warsaw
Warsaw, Warsaw, Poland
Department of Paediatrics, The Medical University of Warsaw
Warsaw, Warsaw, Poland